The California Division of Workers’ Compensation announced updates to the drug list in the Medical Treatment Utilization Schedule to align with national treatment guidelines. The division said the order updates the…

The California Workers’ Compensation Institute reported that a nearly eightfold increase in migraine drug prescriptions coincided with the emergence of several high-cost drugs that are not included in the formulary. “Although…

The Workers Compensation Research Institute is holding a 30-minute webinar Aug. 1 to discuss key findings from its study of interstate variation and trends in work comp drug payments. The WCRI…

Suzanne Honor-Vangerov, CPC, CPC-I, CMSP presents this "2016 Clinical Lab and Drug Test Fee Schedule Update" via webinar. Critical updates, vital solutions and time for Q&A will be provided.

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

Learn about the risks and benefits of these drugs for symptoms of brain injury.

Increased expression of gene PRDM1-S triggers loss of immune regulation seen in autoimmune conditions like multiple sclerosis (MS)

Ubrogepant may be able to prevent or reduce migraine symptoms if taken during the early signs of a migraine attack and before headache begins.

Increased expression of gene PRDM1-S triggers loss of immune regulation seen in autoimmune conditions like multiple sclerosis (MS)

Drug overdoses involving illegal opioids, hallucinogens, stimulants, and sedative psychotropic medications rose by 356% in Colombia between 2010 and 2021.

A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease.

Drug overdoses involving illegal opioids, hallucinogens, stimulants, and sedative psychotropic medications rose by 356% in Colombia between 2010 and 2021.

A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease.

High-grade glioma (HGG), a type of aggressive brain cancer, accounts for the leading cause of cancer-related mortality for children and adolescents. 

Feb 20, 2025, 11am EST

The Tufts CSDD postgraduate course in clinical pharmacology, drug development, and regulation is the longest-running professional development program in the biopharma space. Now in its 52nd year, this unique annual course prepares both new and experienced drug developers, regulators, policy makers, clinical investigators, and academic researchers for success in the life sciences sector. Thousands of drug development professionals are alumni of this prestigious one-of-a-kind program. Top speakers from industry, academia, and the FDA share their expertise to create a highly stimulating and rewarding learning environment.

Location Details: Virtual event via Zoom
Open to Public: No
Primary Audience(s): Faculty, Postdoctoral Fellows, Staff, Students (Graduate)
Event Type: Conference/Panel Event/Symposium, Lecture/Presentation/Seminar/Talk
Subject: Career Development, Health/Wellness, Innovation, Medicine, Science
Event Sponsor Details: Tufts Center for the Study of Drug Development
Event Contact Name: Sarah Wrobel
Event Contact Email: sarah.wrobel@tufts.edu
RSVP Information: secure.touchnet.net…
More info: csdd.tufts.edu…

Feb 13, 2025, 11am EST

The Tufts CSDD postgraduate course in clinical pharmacology, drug development, and regulation is the longest-running professional development program in the biopharma space. Now in its 52nd year, this unique annual course prepares both new and experienced drug developers, regulators, policy makers, clinical investigators, and academic researchers for success in the life sciences sector. Thousands of drug development professionals are alumni of this prestigious one-of-a-kind program. Top speakers from industry, academia, and the FDA share their expertise to create a highly stimulating and rewarding learning environment.

Location Details: Virtual event via Zoom
Open to Public: No
Primary Audience(s): Faculty, Postdoctoral Fellows, Staff, Students (Graduate)
Event Type: Conference/Panel Event/Symposium, Lecture/Presentation/Seminar/Talk
Subject: Career Development, Health/Wellness, Innovation, Medicine, Science
Event Sponsor Details: Tufts Center for the Study of Drug Development
Event Contact Name: Sarah Wrobel
Event Contact Email: sarah.wrobel@tufts.edu
RSVP Information: secure.touchnet.net…
More info: csdd.tufts.edu…

Feb 6, 2025, 11am EST

The Tufts CSDD postgraduate course in clinical pharmacology, drug development, and regulation is the longest-running professional development program in the biopharma space. Now in its 52nd year, this unique annual course prepares both new and experienced drug developers, regulators, policy makers, clinical investigators, and academic researchers for success in the life sciences sector. Thousands of drug development professionals are alumni of this prestigious one-of-a-kind program. Top speakers from industry, academia, and the FDA share their expertise to create a highly stimulating and rewarding learning environment.

Location Details: Virtual event via Zoom
Open to Public: No
Primary Audience(s): Faculty, Postdoctoral Fellows, Staff, Students (Graduate)
Event Type: Conference/Panel Event/Symposium, Lecture/Presentation/Seminar/Talk
Subject: Career Development, Health/Wellness, Innovation, Medicine, Science
Event Sponsor Details: Tufts Center for the Study of Drug Development
Event Contact Name: Sarah Wrobel
Event Contact Email: sarah.wrobel@tufts.edu
RSVP Information: secure.touchnet.net…
More info: csdd.tufts.edu…

Jan 30, 2025, 11am EST

The Tufts CSDD postgraduate course in clinical pharmacology, drug development, and regulation is the longest-running professional development program in the biopharma space. Now in its 52nd year, this unique annual course prepares both new and experienced drug developers, regulators, policy makers, clinical investigators, and academic researchers for success in the life sciences sector. Thousands of drug development professionals are alumni of this prestigious one-of-a-kind program. Top speakers from industry, academia, and the FDA share their expertise to create a highly stimulating and rewarding learning environment.

Location Details: Virtual event via Zoom
Open to Public: No
Primary Audience(s): Faculty, Postdoctoral Fellows, Staff, Students (Graduate)
Event Type: Conference/Panel Event/Symposium, Lecture/Presentation/Seminar/Talk
Subject: Career Development, Health/Wellness, Innovation, Medicine, Science
Event Sponsor Details: Tufts Center for the Study of Drug Development
Event Contact Name: Sarah Wrobel
Event Contact Email: sarah.wrobel@tufts.edu
RSVP Information: secure.touchnet.net…
More info: csdd.tufts.edu…

Proteomics Analysis of Interactions between Drug-Resistant and Drug-Sensitive Cancer Cells: Comparative Studies of Monoculture and Coculture Cell Systems  ACS Publications

Editorial: Mass spectrometry-based proteomics in drug discovery and development  Frontiers

Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics  Nature.com

Apologies to listeners who received two episodes in their feed today. The U.S. is one of two countries in the world that allows pharmaceutical companies to advertise prescription drugs directly to consumers. Why? And what does that do to us Subscribe to our weekly newsletter here.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

As the industry continues to trend toward a more patient-centric approach, we see an increasing buzz around the development and utilization of wearable injectors, also known as on-body delivery systems (OBDS)—the next evolution in needle-based drug delivery products.

Title: Drug Side Effects
Category: RxList - Article
Created: 8/11/2009 12:00:00 AM
Last Editorial Review: 8/15/2022 12:00:00 AM

Some big tests are on the horizon in the area of pharmaceutical tracking as new requirements of the Drug Supply Chain Security Act (DSCSA) take effect.

Antares Vision Group becomes first DSCSA solution provider to join the Pulse Interoperable Partner program of the National Association of Boards of Pharmacy (NABP).

Drugs and Supplements from MedlinePlus - A service of the U.S. National Library of Medicine and National Institutes of Health.

Manufacturing

Stanford Medicine researchers on the hunt for an elusive cardiac fibrosis drug were surprised when a malaria drug with ancient origins emerged as their top candidate.

The post Old drug, new discovery: Scientists find novel use for ancient malaria remedy  appeared first on Scope.

Mesoporous silicon nanoparticles co-deliver chemotherapeutic and genetic drugs with a time lag for more effectively countering cancer-cell protection mechanisms against drugs, as well as inhibiting cell growth and metastasis.

[Namibian] At least 25 Namibians have been arrested in Brazil since 2016 for drug trafficking.

New research reveals that 50% of European and US pharmaceutical manufacturing companies know artificial intelligence (AI) can help bring new drugs to market more rapidly and securely, but 96% face challenges with using leading-edge technology to derive value from their data.

A UK-backed biotech company has achieved a pioneering biocomputer breakthrough which is accelerating the development and manufacture of cheaper drugs and vaccines.

European Commission fines MS drug maker Teva over improper patent use

Location: Law Electronic Resource- 

Location: Main Library- HV5840.M3B57 2004

A survey of employers finds that only about a fifth of large companies cover drugs like Wegovy for weight loss. A majority of companies that do cover the medicines have requirements.

There's something strange going on in hospitals. Cheap, common drugs that nurses use every day seem to be constantly hit by shortages. These are often generic drugs that don't seem super complicated to make, things like dextrose and saline (aka sugar water and salt water).

So what's going on? The answer, as with anything in healthcare, is complicated.

On today's show: why hospitals keep running out of generic drugs. The story behind these shortages tells us a lot about how these drugs are made, bought and sold–and, it shows us how these markets can falter without the proper care.

This episode was hosted by Sally Helm and Alexi Horowitz-Ghazi. It was produced by Willa Rubin, with help from James Sneed and Sam Yellowhorse Kesler. It was edited by Martina Castro. Fact-checking by Dania Suleman. Planet Money's executive producer is Alex Goldmark.

Help support Planet Money and hear our bonus episodes by subscribing to Planet Money+ in Apple Podcasts or at plus.npr.org/planetmoney.

Unless officials take action to develop new medications, drug-resistant infections could kill nearly 2 million people a year in 2050.

Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their own hands.

Explore how on-target precision therapies improve patient outcomes and drug tolerability.

The 'Armchair Expert' host keeps drug test kits at home to assure his wife in case she ever feels unsure whether or not he's sober following his relapse last year.

The woman, who is sued by the member of super group LSD for alleged harassment, is firing back at the DJ, alleging that he's the predator and that his lawsuit is a 'scare tactic.'

The youngest daughter of Ozzy and Sharon Osbourne explains her struggle with weight gain, claiming that she indulged in food after quitting drugs and alcohol.

Conservatives demand council and police act on growing menace.

AILSA CHANG, HOST: Two female firsts in the Supreme Court are retiring. We're talking about the marshal of the court and the reporter of decisions. In 2001, Marshal Pamela Talkin became the first woman to oversee security. Christine Luchok Fallon has been at the court for 31 years, the last nine as the reporter of decisions. NPR legal affairs correspondent Nina Totenberg reports. NINA TOTENBERG, BYLINE: Pam Talkin had been at the Supreme Court in the top security job for less than two months when 9/11 hit. Her first task that morning was to evacuate the building. But Chief Justice Rehnquist was in a conference room conducting his annual meeting with the chief judges from around the country. Talkin sent in a note to no avail. Finally, she walked into the room to get everyone out of there. A month later, the anthrax attack cross-contaminated all the mail in the Capitol complex. And this time, the court had to do something it had never done since the Supreme Court building opened in 1935.

A new study involving a special group of people shows significant overlap between psychedelic trips and near-death experiences. What does the Bible say about the latter?